Glaucoma Lessons From the Deep

What do whale eyes reveal about the disease?

Jacqueline Jeon-Chapman, BS, and David Fleischman, MD, MS, FACS

Glaucoma Today

Customizing Care and Minimizing Risk With MIGS

Reay H. Brown, MD; and Shibandri Das, MD

Eyetube

Needling After subconjunctival stent Implantation With Mitomycin C

Success depends on appropriate patient selection, early recognition of subconjunctival fibrosis, meticulous technique, and aggressive modulation of wound healing.

David S. Jin, and Irfan N. Kherani, MD, FRCSC

Glaucoma Today

Bleb Needling for Reviving a Failed Filter

Restoring function while preserving future surgical options.

Oluwatosin Smith, MD, and Matthew E. Emanuel, MD

Glaucoma Today

Are Nonphysiologic IOP Targets Necessary?

Many patients may achieve disease stability without aggressive goals.

Natalia Londoño De Vivero, MD, and Arsham Sheybani, MD

Glaucoma Today

The Value in Stay and Exit Interviews

The information you stand to learn from these two interview types better positions you to both recruit and retain employees.

Marlon Monelyon-Demeritt, OD, MBA, FAAO

Modern Optometry

EMPOWER - Ocular Surface Disease: Latest Innovations in Dry Eye and Meibomian Gland Dysfunction

Jacob Lang, OD, FAAO, Dipl ABO; Josh Davidson, OD, FAAO, FSLS; and Mark T. Dunbar, OD, FAAO

Eyetube

Narrowing in on Neurotrophic Keratitis

Don’t fall into the trap of associating no pain with dry eye disease.

Jacob Lang, OD, FAAO

Modern Optometry

Psychogenic Amblyopia

Here’s how to differentiate this condition from similar types of vision loss—and how to manage these patients.

Maureen D. Plaumann, OD, PhD, FAAO, Dipl AAO, Ann M. Morrison, OD, PhD, FAAO, Dipl AAO

Modern Optometry

Cataract Surgery: Identifying Postoperative Adverse Events

Know what to look for and how to intervene.

Samantha Rivet, OD

Modern Optometry

The Road Ahead in Glaucoma Treatment

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Jason Bacharach, MD

Eyetube

Oculis Announces Phase 3 Results for DME Eye Drops

Eyetube

Outlook Wins Appeal for Wet AMD Drug Candidate Lytenava

Eyetube

The Journey to Eight-Figure Net Worth

Consider mimicking these five steps to build extraordinary wealth.

Aaron Neufeld, OD

Modern Optometry

Study Examines Semaglutide and Wet AMD Risk

Eyetube